1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Single-Photon Emission Computed Tomography (SPECT) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Single-Photon Emission Computed Tomography (SPECT) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Single-Photon Emission Computed Tomography (SPECT) by Country/Region, 2018, 2022 & 2029
2.2 Single-Photon Emission Computed Tomography (SPECT) Segment by Type
2.2.1 Single Imaging Gamma Cameras
2.2.2 SPECT/CT
2.3 Single-Photon Emission Computed Tomography (SPECT) Sales by Type
2.3.1 Global Single-Photon Emission Computed Tomography (SPECT) Sales Market Share by Type (2018-2023)
2.3.2 Global Single-Photon Emission Computed Tomography (SPECT) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Single-Photon Emission Computed Tomography (SPECT) Sale Price by Type (2018-2023)
2.4 Single-Photon Emission Computed Tomography (SPECT) Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Imaging Centres
2.4.3 Ambulatory Surgical Centres
2.5 Single-Photon Emission Computed Tomography (SPECT) Sales by Application
2.5.1 Global Single-Photon Emission Computed Tomography (SPECT) Sale Market Share by Application (2018-2023)
2.5.2 Global Single-Photon Emission Computed Tomography (SPECT) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Single-Photon Emission Computed Tomography (SPECT) Sale Price by Application (2018-2023)
3 Global Single-Photon Emission Computed Tomography (SPECT) by Company
3.1 Global Single-Photon Emission Computed Tomography (SPECT) Breakdown Data by Company
3.1.1 Global Single-Photon Emission Computed Tomography (SPECT) Annual Sales by Company (2018-2023)
3.1.2 Global Single-Photon Emission Computed Tomography (SPECT) Sales Market Share by Company (2018-2023)
3.2 Global Single-Photon Emission Computed Tomography (SPECT) Annual Revenue by Company (2018-2023)
3.2.1 Global Single-Photon Emission Computed Tomography (SPECT) Revenue by Company (2018-2023)
3.2.2 Global Single-Photon Emission Computed Tomography (SPECT) Revenue Market Share by Company (2018-2023)
3.3 Global Single-Photon Emission Computed Tomography (SPECT) Sale Price by Company
3.4 Key Manufacturers Single-Photon Emission Computed Tomography (SPECT) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Single-Photon Emission Computed Tomography (SPECT) Product Location Distribution
3.4.2 Players Single-Photon Emission Computed Tomography (SPECT) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Single-Photon Emission Computed Tomography (SPECT) by Geographic Region
4.1 World Historic Single-Photon Emission Computed Tomography (SPECT) Market Size by Geographic Region (2018-2023)
4.1.1 Global Single-Photon Emission Computed Tomography (SPECT) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Single-Photon Emission Computed Tomography (SPECT) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Single-Photon Emission Computed Tomography (SPECT) Market Size by Country/Region (2018-2023)
4.2.1 Global Single-Photon Emission Computed Tomography (SPECT) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Single-Photon Emission Computed Tomography (SPECT) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Single-Photon Emission Computed Tomography (SPECT) Sales Growth
4.4 APAC Single-Photon Emission Computed Tomography (SPECT) Sales Growth
4.5 Europe Single-Photon Emission Computed Tomography (SPECT) Sales Growth
4.6 Middle East & Africa Single-Photon Emission Computed Tomography (SPECT) Sales Growth
5 Americas
5.1 Americas Single-Photon Emission Computed Tomography (SPECT) Sales by Country
5.1.1 Americas Single-Photon Emission Computed Tomography (SPECT) Sales by Country (2018-2023)
5.1.2 Americas Single-Photon Emission Computed Tomography (SPECT) Revenue by Country (2018-2023)
5.2 Americas Single-Photon Emission Computed Tomography (SPECT) Sales by Type
5.3 Americas Single-Photon Emission Computed Tomography (SPECT) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Single-Photon Emission Computed Tomography (SPECT) Sales by Region
6.1.1 APAC Single-Photon Emission Computed Tomography (SPECT) Sales by Region (2018-2023)
6.1.2 APAC Single-Photon Emission Computed Tomography (SPECT) Revenue by Region (2018-2023)
6.2 APAC Single-Photon Emission Computed Tomography (SPECT) Sales by Type
6.3 APAC Single-Photon Emission Computed Tomography (SPECT) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Single-Photon Emission Computed Tomography (SPECT) by Country
7.1.1 Europe Single-Photon Emission Computed Tomography (SPECT) Sales by Country (2018-2023)
7.1.2 Europe Single-Photon Emission Computed Tomography (SPECT) Revenue by Country (2018-2023)
7.2 Europe Single-Photon Emission Computed Tomography (SPECT) Sales by Type
7.3 Europe Single-Photon Emission Computed Tomography (SPECT) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Single-Photon Emission Computed Tomography (SPECT) by Country
8.1.1 Middle East & Africa Single-Photon Emission Computed Tomography (SPECT) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Single-Photon Emission Computed Tomography (SPECT) Revenue by Country (2018-2023)
8.2 Middle East & Africa Single-Photon Emission Computed Tomography (SPECT) Sales by Type
8.3 Middle East & Africa Single-Photon Emission Computed Tomography (SPECT) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Single-Photon Emission Computed Tomography (SPECT)
10.3 Manufacturing Process Analysis of Single-Photon Emission Computed Tomography (SPECT)
10.4 Industry Chain Structure of Single-Photon Emission Computed Tomography (SPECT)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Single-Photon Emission Computed Tomography (SPECT) Distributors
11.3 Single-Photon Emission Computed Tomography (SPECT) Customer
12 World Forecast Review for Single-Photon Emission Computed Tomography (SPECT) by Geographic Region
12.1 Global Single-Photon Emission Computed Tomography (SPECT) Market Size Forecast by Region
12.1.1 Global Single-Photon Emission Computed Tomography (SPECT) Forecast by Region (2024-2029)
12.1.2 Global Single-Photon Emission Computed Tomography (SPECT) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Single-Photon Emission Computed Tomography (SPECT) Forecast by Type
12.7 Global Single-Photon Emission Computed Tomography (SPECT) Forecast by Application
13 Key Players Analysis
13.1 GE Healthcare
13.1.1 GE Healthcare Company Information
13.1.2 GE Healthcare Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.1.3 GE Healthcare Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GE Healthcare Main Business Overview
13.1.5 GE Healthcare Latest Developments
13.2 Siemens Healthcare
13.2.1 Siemens Healthcare Company Information
13.2.2 Siemens Healthcare Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.2.3 Siemens Healthcare Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Siemens Healthcare Main Business Overview
13.2.5 Siemens Healthcare Latest Developments
13.3 Koninklijke Philips N.V.
13.3.1 Koninklijke Philips N.V. Company Information
13.3.2 Koninklijke Philips N.V. Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.3.3 Koninklijke Philips N.V. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Koninklijke Philips N.V. Main Business Overview
13.3.5 Koninklijke Philips N.V. Latest Developments
13.4 Bruker Corporation
13.4.1 Bruker Corporation Company Information
13.4.2 Bruker Corporation Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.4.3 Bruker Corporation Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bruker Corporation Main Business Overview
13.4.5 Bruker Corporation Latest Developments
13.5 Mediso Ltd.
13.5.1 Mediso Ltd. Company Information
13.5.2 Mediso Ltd. Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.5.3 Mediso Ltd. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mediso Ltd. Main Business Overview
13.5.5 Mediso Ltd. Latest Developments
13.6 Toshiba Medical (Canon)
13.6.1 Toshiba Medical (Canon) Company Information
13.6.2 Toshiba Medical (Canon) Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.6.3 Toshiba Medical (Canon) Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Toshiba Medical (Canon) Main Business Overview
13.6.5 Toshiba Medical (Canon) Latest Developments
13.7 Digirad Corporation
13.7.1 Digirad Corporation Company Information
13.7.2 Digirad Corporation Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.7.3 Digirad Corporation Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Digirad Corporation Main Business Overview
13.7.5 Digirad Corporation Latest Developments
13.8 Spectrum Dynamics Medical
13.8.1 Spectrum Dynamics Medical Company Information
13.8.2 Spectrum Dynamics Medical Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.8.3 Spectrum Dynamics Medical Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Spectrum Dynamics Medical Main Business Overview
13.8.5 Spectrum Dynamics Medical Latest Developments
13.9 DDD-Diagnostic A/S
13.9.1 DDD-Diagnostic A/S Company Information
13.9.2 DDD-Diagnostic A/S Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.9.3 DDD-Diagnostic A/S Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 DDD-Diagnostic A/S Main Business Overview
13.9.5 DDD-Diagnostic A/S Latest Developments
13.10 MiE America, Inc.
13.10.1 MiE America, Inc. Company Information
13.10.2 MiE America, Inc. Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.10.3 MiE America, Inc. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 MiE America, Inc. Main Business Overview
13.10.5 MiE America, Inc. Latest Developments
13.11 CardiArc
13.11.1 CardiArc Company Information
13.11.2 CardiArc Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.11.3 CardiArc Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 CardiArc Main Business Overview
13.11.5 CardiArc Latest Developments
13.12 Beijing Hamamatsu Photon Techniques INC.
13.12.1 Beijing Hamamatsu Photon Techniques INC. Company Information
13.12.2 Beijing Hamamatsu Photon Techniques INC. Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.12.3 Beijing Hamamatsu Photon Techniques INC. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Beijing Hamamatsu Photon Techniques INC. Main Business Overview
13.12.5 Beijing Hamamatsu Photon Techniques INC. Latest Developments
13.13 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
13.13.1 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. Company Information
13.13.2 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.13.3 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. Main Business Overview
13.13.5 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. Latest Developments
13.14 PNPMed
13.14.1 PNPMed Company Information
13.14.2 PNPMed Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.14.3 PNPMed Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 PNPMed Main Business Overview
13.14.5 PNPMed Latest Developments
13.15 NuCare Inc.
13.15.1 NuCare Inc. Company Information
13.15.2 NuCare Inc. Single-Photon Emission Computed Tomography (SPECT) Product Portfolios and Specifications
13.15.3 NuCare Inc. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 NuCare Inc. Main Business Overview
13.15.5 NuCare Inc. Latest Developments
14 Research Findings and Conclusion
| ※参考情報 単一光子放射型コンピュータ断層撮影法（SPECT）は、医療診断において重要な役割を果たす画像診断技術の一つです。この技術は、放射性同位元素が放出する単一光子を利用して、体内の生理学的な機能を視覚化するための方法です。以下に、SPECTの概念について詳述いたします。 SPECTは、主に心臓や脳、腫瘍などの診断に利用されます。得られる画像は、放射性トレーサー（造影剤）による体内の局所的な血流や代謝活動を示し、疾患の早期発見や進行度の評価に役立ちます。特に、SPECTは脳血流の評価や心筋の血流と機能を評価するために用いられることが多く、それにより様々な疾患の診断、評価、治療効果のモニタリングを行うことができます。 SPECTの特徴としては、非侵襲的であることが挙げられます。患者の体に物理的な負担をかけず、外部から放射線を感知することで画像を取得します。また、比較的容易に実施でき、特定の組織に集積した放射性トレーサーによって高感度な情報を取得できることから、他の画像診断技術に比べ、広範な応用が可能です。 この技術は、常に進化を続けており、特にトレーサーの種類によって多様な応用があることが特徴です。例えば、心臓病の診断には、心筋の血流を評価するためにテクネシウム（99mTc）を用いたトレーサーが広く利用されています。一方、脳機能の評価には、フルオロデオキシグルコース（FDG）などのグルコース代謝を反映するトレーサーが使われます。SPECTは、さまざまな放射性同位元素を使用した結果、豊富な情報を得ることができるのです。 また、SPECTはCT（コンピュータ断層撮影）やMRI（磁気共鳴画像法）と組み合わせることも可能です。これにより、解剖学的な情報と生理的な情報を統合的に評価することができ、より詳細な解析が可能となります。これを「SPECT/CT」や「SPECT/MRI」と呼び、近年の医学画像診断において重要な位置を占めています。 SPECTの主な用途としては、心筋シンチグラフィーや脳血流シンチグラフィーなどがあります。心筋シンチグラフィーは、心筋への血流の量や分布を評価するために用いられる方法であり、冠動脈疾患の診断に役立ちます。脳血流シンチグラフィーは、脳の血流パターンを評価し、脳卒中や神経変性疾患の診断に貢献します。これにより、診療方針の決定や治療効果のモニタリングがより精緻に行えるようになっています。 SPECTの関連技術としては、PET（陽電子放出断層撮影）があります。PETは、放射性同位元素から放出される陽電子を利用しており、SPECTと比べると高い感度と解像度を持っているため、代謝・機能の評価に非常に優れています。しかし、SPECTはより広く普及しているため、PETに比べて利用が容易であり、コストの面でも優位です。 放射性トレーサーの研究開発も進んでおり、新たなトレーサーが登場することで、SPECTの診断能力は向上しています。例えば、特定の腫瘍マーカーに結合するトレーサーの開発により、がんの早期発見が可能になりつつあります。また、βアミロイドを特異的に標識するトレーサーなど、認知症の診断に特化したトレーサーも開発されています。 医療現場では、SPECTの技術が進歩することにより患者の診断や治療の選択肢が増え、それに伴い患者の予後も改善する可能性が高まっています。今後も、SPECT技術の進展により、新たな診断法や治療法が生まれることが期待されています。 さらに、SPECTの画像解析技術も重要な進歩を遂げています。従来の視覚的評価に加えて、AI（人工知能）や機械学習を用いた解析手法が導入されることで、より客観的かつ迅速な診断が可能になっています。これにより、膨大な画像データを効率的に処理し、高精度な結果を得ることができるようになるでしょう。 単一光子放射型コンピュータ断層撮影法（SPECT）は、画像診断技術の中でも非常に重要な役割を果たしています。その非侵襲的なアプローチ、多様な放射性トレーサーの利用、他の技術との組み合わせ、さらに進化を続ける解析手法などにより、医療現場においてその重要性は今後も増加することでしょう。SPECTは、疾患の早期発見や治療効果のモニタリングに貢献し、患者の健康を守るための強力なツールであるといえます。このように、SPECTは現代の医療に欠かせない技術の一つであり、引き続き注目を集めることが予想されます。 |
